OOIR: Observatory of International Research

Papers

(The H4-Index of Pharmacological Reviews is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies	386
Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options	374
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels	247
Is Oxytocin “Nature’s Medicine”?	198
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges	192
Rescuing the Last-Line Polymyxins: Achievements and Challenges	174
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development	160
Subcellular Organization of the cAMP Signaling Pathway	143
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function	136
The Noncanonical Pathway for In Vivo Nitric Oxide Generation: The Nitrate-Nitrite-Nitric Oxide Pathway	134
Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials	117
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms	108
Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology	98
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics	98
Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950	89
Sex- and Gender-Based Pharmacological Response to Drugs	86
Post-Translational Modifications of G Protein–Coupled Receptors Control Cellular Signaling Dynamics in Space and Time	86
On the Clinical Pharmacology of Reactive Oxygen Species	72
Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review	68
International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update	68
Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?	66
Mutations in G Protein–Coupled Receptors: Mechanisms, Pathophysiology and Potential Therapeutic Approaches	63
International Union of Basic and Clinical Pharmacology. CVIII. Calcium-Sensing Receptor Nomenclature, Pharmacology, and Function	62
Unlocking G-Quadruplexes as Antiviral Targets	61
Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species	61

Animal Models of Drug Relapse and Craving after Voluntary Abstinence: A Review	61
Sex Differences in the Epilepsies and Associated Comorbidities: Implications for Use and Development of Pharmacotherapies	60
E1 Enzymes as Therapeutic Targets in Cancer	58
Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications	56
Dopamine, Immunity, and Disease	56
Aldo-Keto Reductases and Cancer Drug Resistance	55
Inhaled Medicines: Past, Present, and Future	46
Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury	44
Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors	41
Therapeutics in the Pipeline Targetingα-Synuclein for Parkinson's Disease	41
Neurobiological Mechanisms of Nicotine Reward and Aversion	40
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications	39
Nonantimicrobial Actions of Macrolides: Overview and Perspectives for Future Development	39
ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain	38